Table 3. Subgroup analysis for association between EGFR expression and overall survival in GC patients.
Overall survival | 95%CI | Heterogeneity | |||||
---|---|---|---|---|---|---|---|
Group factors | Subgroup | HR | P value | Lower | Upper | I 2 | P value |
Total | Total | 1.19 | 0.015 | 1.04 | 1.37 | 66.4% | 0.001 |
Contain stage IV patients | Yes | 1.11 | 0.302 | 0.91 | 1.37 | 55.9% | 0.059 |
No | 1.22 | 0.052 | 1.0 | 1.5 | 65.4% | 0.001 | |
Chemistry therapy | Yes | 1.21 | 0.291 | 0.85 | 1.71 | 65.4% | 0.008 |
No | 1.18 | 0.042 | 1.01 | 1.38 | 65.8% | 0.001 | |
Patients number≥100 | Yes | 1.13 | 0.113 | 0.97 | 1.31 | 68.5% | 0.001 |
No | 1.44 | 0.044 | 1.01 | 2.05 | 48.3% | 0.06 | |
Positive rate≥50% | Yes | 1.04 | 0.744 | 0.84 | 1.28 | 54.7% | 0.024 |
No | 1.29 | 0.012 | 1.06 | 1.59 | 63.1% | 0.001 |
HR, hazard ratio; CI, confidence interval.